Point72 Hong Kong’s Bristol-Myers Squibb BMY Stock Holding History

Point72 Hong Kong’s Portfolio BMY Stock Details BMY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q4	–	Sell	-154,300	Closed	-$11M	–	277
2022 Q3	$11M	Buy	154,300 +140,600	+1,026%	+$10.2M	0.38%	42
2022 Q2	$1.05M	Buy	13,700 +3,200	+30%	+$244K	0.04%	512
2022 Q1	$767K	Sell	10,500 -76,100	-88%	-$5.11M	0.03%	595
2021 Q4	$5.4M	Buy	86,600 +48,100	+125%	+$2.82M	0.19%	101
2021 Q3	$2.28M	Buy	38,500 +12,000	+45%	+$790K	0.07%	397
2021 Q2	$1.77M	Sell	26,500 -23,600	-47%	-$1.54M	0.06%	474
2021 Q1	$3.16M	Buy	50,100 +26,900	+116%	+$1.67M	0.11%	253
2020 Q4	$1.44M	Buy	+23,200	New	+$1.43M	0.07%	367

Other funds holding BMY

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return

Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Point72 Hong Kong's BMY Position: Q3 2025 in Review

Point72 Hong Kong opened a new position in Bristol-Myers Squibb (BMY) in Q3 2025: 132,171 shares worth $5.96M. The stake represents 0.27% of the portfolio and ranks #72 among its holdings. This is a return to the name: Point72 Hong Kong previously reported a position in BMY as recently as Q4 2024.

Point72 Hong Kong first reported a position in BMY in Q1 2015 and has held it in 25 quarters since. The position peaked at $15.3M in Q4 2024. 2,268 funds tracked by Wall St. Rank hold BMY as of Q3 2025.

Point72 Hong Kong held 132,171 shares of Bristol-Myers Squibb worth $5.96M as of Q3 2025.
Bristol-Myers Squibb was a new Point72 Hong Kong position in Q3 2025.
Bristol-Myers Squibb made up 0.27% of Point72 Hong Kong's portfolio in Q3 2025, its #72 holding.
Point72 Hong Kong first reported a position in Bristol-Myers Squibb in Q1 2015 and has held it in 25 quarters since.
Point72 Hong Kong's Bristol-Myers Squibb position peaked at $15.3M in Q4 2024.
2,268 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q3 2025.

Based on Point72 Hong Kong's 13F filing for Q3 2025, filed 14 Nov 2025.